+91-9896593699

DRDEEPAKSHUKLA https://www.cancerinfo.in
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

919896539256

Maintenance with PARP inhibitor is the way forward in ovarian cancer:Median PFS in platinum sensitive relapse carcinoma ovary is approximately 10 months.20% of high grade serous carcinoma ovary have somatic or germline mutation in BRCA gene.Sin

Redefining low grade glioma ( a type of brain tumor ) using WHO 2016 classification:Clinical presentation of low grade glioma is usually with new onset seizureRadiologically low grade glioma are hyperintense on T2 MRI images and do not show contr

ERA OF PERSONALISED MEDICINE IN METASTATIC ADENOCARCINOMA LUNG:Stage IV adenocarcinoma is not a single disease. Different molecular subtypes of NSCLC have been identified and the treatment approach is different for each subtype.The different mole

SCREENING MAMMOGRAPHY - A UNDERUTILISED TOOL AGAINST BREAST CANCER IN INDIAIndian context of breast cancer:Breast cancer is the most common cancer diagnosed in india, close 1.5 lakh new cases are diagnosed each year.It Constitutes around 10% of

Liquid biopsy in non small cell lung cancer is now being used for detection of EGFR mutation analysis in patients who do not have accessible tissue for conventional testing and based on the platform used for liquid biopsy ie digital v/s nondigital it

A case report of newly diagnosed epithelial ovarian carcinoma presenting with spontaneous tumor lysis syndrome and its successful management with rasburicaseDr Deepak Kumar Shuklahttp://www.ijmpo.org/text.asp?2017/38/3/360/216841

Pregnancy and cancer: A challenge for obstetrician and oncologist!As the age of child birth is delayed we may be seeing more cases with cancer in pregnancy.At present estimated incidence of cancer in pregnancy is estimated to be around 1 in 1000

IMMUNOTHERAPY IN LUNG CANCER- THE FUTURE OF CANCER CARE.Any cancer and lung cancer in particular creates a highly immunosuppressive environment locally i.e. our bodies immune cells are unable to recognize cancer cells.This is made possible by exp

services